![Elyse Stock](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Elyse Stock
Director/Board Member at
Areteia Therapeutics, Inc.
Profile
Dr. Elyse Stock, MD, is a Chief Medical Officer at Biohaven Pharmaceutical Holding Co. Ltd. She received her doctorate degree from New York University School of Medicine.
Elyse Stock active positions
| Companies | Position | Start |
|---|---|---|
Areteia Therapeutics, Inc.
 Areteia Therapeutics, Inc. BiotechnologyHealth Technology Operates as biotechnology company | Director/Board Member | 17/04/2023 |
Former positions of Elyse Stock
| Companies | Position | End |
|---|---|---|
| BIOHAVEN PHARMACEUTICAL HOLDING COMPANY LTD. | Chief Tech/Sci/R&D Officer | 03/10/2022 |
Training of Elyse Stock
Experiences
Positions held
Active
Inactive
Listed companies
Private companies
Connections
13
1st degree connections
3
1st degree companies
Male
Female
Members of the board
Executives
Linked companies
| Private companies | 3 |
|---|---|
New York University School of Medicine
 New York University School of Medicine Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Biohaven Pharmaceutical Holding Co. Ltd.
 Biohaven Pharmaceutical Holding Co. Ltd. Pharmaceuticals: MajorHealth Technology Operates as a biopharmaceutical company that develops drugs to treat neurological and neuropsychiatric diseases | Health Technology |
Areteia Therapeutics, Inc.
Areteia Therapeutics, Inc. BiotechnologyHealth Technology Operates as biotechnology company | Health Technology |
- Stock Market
- Insiders
- Elyse Stock
